Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RGEN✓SelectedUSD · RGENGSK vs RGEN performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs RGEN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
RGEN return
-42.4%
Excess return
+83.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioRGENExcessAlpha
1D-0.1%-3.8%+3.7%+0.1%
7D-5.3%-2.4%-3.0%-5.2%
30D-3.7%-9.0%+5.3%-3.1%
3M-7.3%-9.1%+1.9%-6.8%
6M-4.2%+46.6%-50.8%-7.4%
YTD+0.9%0.0%+0.9%0.0%
1Y+7.3%+6.1%+1.2%+5.9%
3Y+52.7%+5.2%+47.5%+48.4%
All+41.1%-42.4%+83.5%+33.8%

Cumulative growth

Daily Returns

Daily percentage return beside RGEN.

Daily Out/Under-Performance

Portfolio return minus RGEN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling